One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying
Lowe, Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer
When deciding between SBIR and STTR, consider what formal partnerships you will need, the distribution of research work, and the agency that aligns with your proposed project
While some studies indicate higher doses may be effective for specific conditions, consult a healthcare professional before exceeding 1,000 mg per day
If switching contraception methods feels inconvenient, discuss your specific birth control regimen with your PlexusDx prescriber during your initial consultation
